相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vaccination Against Dengue: Challenges and Current Developments
Bruno Guy et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Protective and immunological behavior of chimeric yellow fever dengue vaccine
Scott B. Halstead et al.
VACCINE (2016)
CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
Raphael M. Zellweger et al.
JOURNAL OF VIROLOGY (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
P. Robert Beatty et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
Naphak Modhiran et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Functionality of Dengue Virus Specific Memory T Cell Responses in Individuals Who Were Hospitalized or Who Had Mild or Subclinical Dengue Infection
Chandima Jeewandara et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2
Lazaro Gil et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
The Human CD8(+) T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
Daniela Weiskopf et al.
JOURNAL OF VIROLOGY (2015)
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
Edith Suzarte et al.
ARCHIVES OF VIROLOGY (2014)
CD8+ T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice
Raphael M. Zellweger et al.
JOURNAL OF IMMUNOLOGY (2014)
Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
Roland Zuest et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Capsid protein: Evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys
Lazaro Gil et al.
VIROLOGY (2014)
Vaccine-mediated immunity against dengue and the potential for long-term protection against disease
Mark K. Slifka
FRONTIERS IN IMMUNOLOGY (2014)
T-cell immunity to infection with dengue virus in humans
Daniela Weiskopf et al.
FRONTIERS IN IMMUNOLOGY (2014)
Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus
Ernesto Marcos et al.
ARCHIVES OF VIROLOGY (2013)
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Maria G. Guzman et al.
ARCHIVES OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
Raphael M. Zellweger et al.
PLOS PATHOGENS (2013)
Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice
Lazaro Gil et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Gamma Interferon (IFN-γ) Receptor Restricts Systemic Dengue Virus Replication and Prevents Paralysis in IFN-α/β Receptor-Deficient Mice
Tyler R. Prestwood et al.
JOURNAL OF VIROLOGY (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Molecular mimicry between virus and host and its implications for dengue disease pathogenesis
Yee-Shin Lin et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
Laura Lazo et al.
ARCHIVES OF VIROLOGY (2010)
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
Raphael M. Zellweger et al.
CELL HOST & MICROBE (2010)
Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use
Iris Valdes et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Thaneeya Duangchinda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus
Carlos Lopez et al.
ARCHIVES OF VIROLOGY (2009)
Viremia and the Magnitude of the Immune Response upon Infection of Green Monkeys with Dengue Virus Type 2 Are Strain-Dependent
Jorge Martin et al.
CURRENT MICROBIOLOGY (2009)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice
Iris Valdes et al.
VIROLOGY (2009)
Mouse models of dengue virus infection and disease
Lauren E. Yauch et al.
ANTIVIRAL RESEARCH (2008)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention
Ana P. Goncalvez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
T cell responses in dengue hemorrhagic fever: Are cross-reactive T cells suboptimal?
Juthathip Mongkolsapaya et al.
JOURNAL OF IMMUNOLOGY (2006)
Dengue: defining protective versus pathologic immunity
AL Rothman
JOURNAL OF CLINICAL INVESTIGATION (2004)
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, Whereas T- and B-cell-dependent immunity are less critical
S Shresta et al.
JOURNAL OF VIROLOGY (2004)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
J Mongkolsapaya et al.
NATURE MEDICINE (2003)
Chimeric yellow fever/dengue virus as a candidate dengue vaccine: Quantitation of the dengue virus-specific CD8 T-cell response
RG Van Der Most et al.
JOURNAL OF VIROLOGY (2000)
分享论文
